Anthropic Just Gave Wall Street Something The Rest Of The AI Industry Hasn’t: A Profit

Anthropic told prospective investors this week that third-quarter revenue surged 45% to $16.8 billion and the company generated positive adjusted earnings for the second consecutive quarter, giving Wall Street an unusually concrete answer to the question hanging over the AI boom. Frontier artificial intelligence can consume astonishing amounts of capital, but Anthropic is beginning to show that at least one company can make money while doing it. 

The numbers emerged Wednesday at a San Francisco meeting with public-market investors as Anthropic prepares for a possible IPO after the midterm elections. Revenue rose from $4.7 billion in the first quarter to $11.6 billion in the second before reaching $16.8 billion in the third, putting the Claude maker on a trajectory few companies of any kind have ever experienced. 

That performance makes Anthropic an awkward counterexample to the growing anxiety surrounding AI economics. Technology companies are committing hundreds of billions of dollars to chips, data centers and power while investors wait for evidence that revenue generated by artificial intelligence can eventually justify the infrastructure being built around it. Anthropic is still spending aggressively, but its business is beginning to demonstrate that the revenue side of that equation can become enormous too.

CEO Dario Amodei has made an unusually concentrated bet on business customers rather than trying to win every corner of the consumer AI market. Claude has become particularly strong in coding and enterprise applications, where customers can attach a direct economic value to work the models perform. That positioning has allowed Anthropic to grow without matching every expensive consumer initiative pursued elsewhere in the industry. 

The company is hardly capital-light. Anthropic has committed more than $500 billion to cloud computing and infrastructure over the coming decade, while Amazon and Alphabet remain both major investors and critical infrastructure partners. Its confidential IPO filing also shows how expensive the climb has been: Anthropic lost more than $8 billion from operations in 2025 even as revenue increased twelvefold to $4.6 billion. 

That history is what makes the recent profitability more consequential than another spectacular growth number. Investors already know AI companies can attract customers and capital at extraordinary speed. What remains unresolved is whether the economics eventually improve as usage scales, or whether every additional dollar of revenue requires another uncomfortable amount of computing expenditure behind it.

Anthropic is beginning to argue for the first outcome. The company was cash-flow positive last quarter and adjusted-profitable for the second consecutive quarter, while analysts believe its annual revenue run rate could exceed $110 billion by year-end. Those figures don't eliminate the enormous infrastructure obligations ahead, but they begin replacing projections about future AI economics with operating evidence. 

There is a complication inside all that growth. Revenue increased roughly 45% sequentially in the third quarter after rising far faster between the first and second quarters, and some analysts had expected Anthropic to reach an even higher run rate by now. A business approaching public markets can't remain a hypergrowth startup forever, particularly if investors eventually attach something close to the $2 trillion valuation being discussed for its debut. 

That creates a remarkable standard for Amodei to maintain. Anthropic can report $16.8 billion of quarterly revenue, positive adjusted earnings and positive cash flow and still face questions about whether growth is slowing too quickly. The AI boom has inflated expectations along with valuations.

But Anthropic has moved the argument somewhere important. The central question is no longer whether anybody can build a huge business selling frontier AI. One already exists and appears capable of producing a profit.

Now Wall Street gets to decide what that evidence is worth.